Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cell. 2010 Aug 20;142(4):511-2. doi: 10.1016/j.cell.2010.08.004.

Reversing cachexia.

Author information

  • 1Nutritional Biomedicine, School of Life and Health Sciences, Aston University, Birmingham B4 7ET, UK. m.j.tisdale@aston.ac.uk

Abstract

Muscle atrophy (cachexia) in cancer patients is a life-threatening condition for which therapeutic options are limited. Zhou et al. (2010) now identify a new target for treating cachexia, the activin type-2 receptor (ActRIIB). In several mouse models of cachexia, the authors reversed wasting of skeletal and cardiac muscle and increased life span by blocking ActRIIB with a decoy receptor.

Copyright 2010 Elsevier Inc. All rights reserved.

PMID:
20723750
[PubMed]
Free full text

Publication Types

Publication Types

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk